Hang Lung Group Ltd. reported audited consolidated cash flow results for the year ended December 31, 2012. For the period, the company reported net cash generated from operating activities was HKD 5,150 million compared to HKD 2,726 million a year ago. Payment for fixed assets was HKD 5,360 million compared to HKD 9,769 million a year ago. The directors of company recommend a final dividend of HKD 60 cents per share which, together with the interim dividend of HKD 19 cents per share paid on September 13, 2012, makes a total of HKD 79 cents per share in respect of the year ended December 31, 2012. The proposed final dividend, if approved by the shareholders at the annual general meeting on April 18, 2013, will be paid on May 8, 2013 to shareholders whose names appear on the register of members on April 24, 2013.

Hang Lung Group Ltd. reported unaudited consolidated earnings results for the year ended December 31, 2012. For the period, turnover was HKD 7,986 million against HKD 3,361 million a year ago. Operating profit after change in fair value of investment properties was HKD 11,491 million against HKD 3,525 million a year ago. Profit before taxation was HKD 11,309 million against HKD 3,617 million a year ago. Profit for the year attributable to shareholders was HKD 5,262 million or HKD 3.87 per diluted share against HKD 1,578 million or HKD 1.16 per diluted share a year ago.

Hang Lung Group Ltd., Annual General Meeting, Apr 18, 2013., at 11:00 China Standard Time. Location: Grand Ballroom, Lower Lobby, Conrad Hong Kong. Agenda: To consider the audited financial statements and reports of the directors and auditor for the year ended December 31, 2012; to declare a final dividend; to re-elect directors and authorize the board of directors to fix directors' fees; to re-appoint auditor and authorize the directors to fix their remuneration; to authorize directors during the relevant period all the powers of the company to purchase shares in the capital of the company; and to authorize directors during the relevant period all the powers of the company to allot, issue and deal with additional shares in the capital of the company and to allot, issue or grant securities convertible into shares in the capital of the company or options, warrants or similar rights to subscribe for any such shares or such convertible securities and to make or grant offers, agreements and options which might require the exercise of such powers.